The global Prenatal and new-born genetic testing market accrued earnings worth approximately 4.7(USD Billion) in 2020 and is predicted to gain revenue of about 10.11(USD Billion) by 2028, is set to record a CAGR of nearly 11.8% over the period from 2021 to 2028.
The global Prenatal and new-born genetic testing Market accrued earnings worth approximately 4.7(USD Billion) in 2020 and is predicted to gain revenue of about 10.11(USD Billion) by 2028, is set to record a CAGR of nearly 11.8% over the period from 2021 to 2028. The report offers an assessment and analysis of the Prenatal and newborn genetic testing market on a global and regional level. The study offers a comprehensive assessment of the market competition, constraints, revenue estimates, opportunities, evolving trends, and industry-validated data. The report provides historical data from 2018 to 2020 along with a forecast from 2021 to 2028 based on revenue (USD Billion).
Report Attribute | Details |
---|---|
Base Year | 2020 |
Historic Years | 2016 - 2020 |
Forecast Years | 2021 - 2028 |
Segments Covered | By Product Type, By Application, and By End Use |
Forecast Units | Value (USD Billion), and Volume (Units) |
Quantitative Units | Revenue in USD million/billion and CAGR from 2021 to 2028 |
Regions Covered | North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World |
Countries Covered | U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others |
Number of Companies Covered | 10 companies with scope for including additional 15 companies upon request |
Report Coverage | Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis. |
Customization Scope | Avail customized purchase options to meet your exact research needs. |
Prenatal testing is referred to as medical tests performed during pregnancy to determine genetic disorders as well as birth defects in the fetus. Generally, these tests are carried out for detecting Tay-Sachs disease, sickle cell anemia, cystic fibrosis, and Down’s syndrome. Screening is continued post-baby birth and this testing is named newborn genetic testing. It is performed for determining genetically inherited disorders and phenylketonuria, critical congenital heart ailment, hearing loss, and muscular spinal atrophy. Prenatal and newborn genetic screening helps in reducing infant mortalities and enhances patient health by enabling effective diagnosis & treatment.
Technological breakthroughs in healthcare & growing awareness about the advantages of prenatal & newborn genetic testing activities will steer prenatal and newborn genetic testing market growth. The surge in chromosomal disorders and the occurrence of hereditary diseases will propel business growth. In addition to this, a prominent rise in acceptance of non-invasive prenatal testing activities will scale up the expansion of the prenatal and newborn genetic testing industry size during the forecast timeline. The growing occurrence of genetic disorders in infants has translated into the need for prenatal and newborn genetic testing activities, thereby driving prenatal and newborn genetic testing market trends. However, ethical issues pertaining to prenatal & newborn genetic testing and cultural barriers can impede the growth of the prenatal and newborn genetic testing industry growth over the years ahead.
North America To Maintain Market Dominance During Forecast Timespan
The regional market dominance of North America over 2021-2028 can be due to supportive government healthcare policies along with the easy availability of new bio-techniques including real-time PCR and multiplex PCR systems. Apart from this, the rise in cases of genetic diseases in infants and demand for minimally invasive genetic screening in countries such as the U.S. will create lucrative growth avenues for the prenatal and newborn genetic testing market in North America over the forecast period. The surge in pregnancies in women after 35 years has posed a risk of a child being born with anomalies and this has prompted the need for prenatal and newborn genetic testing activities, thereby promulgating growth in the size of the prenatal and newborn genetic testing market in the North American sub-continent.
Key participants profiled in the report and influencing market growth are Natera, Ariosa Diagnostics (Roche), Trivitron Healthcare, Sequenom, Berry Genomics, Qiagen, BGI, Biorad, Illumina, Laboratory Corporation of America, and Verinata Health.
The global Prenatal and new-born genetic testing Market is segmented as follows:
List of Figures
1. Market research Type
2. Market research methodology
3. Global Prenatal and new-born genetic testing Market, 2018–2028(USD Billion)
4. Porter’s Five Forces Analysis
5. Global Prenatal and new-born genetic testing Marketattractiveness, By Technology
6. Global Prenatal and new-born genetic testing Marketattractiveness, By End-Use
7. Global Prenatal and new-born genetic testing Marketshare by Technology ,2020 and 2028 (USD Billion)
8. Global Prenatal and new-born genetic testing Marketby Screening, 2018–2028(USD Billion)
9. Global Prenatal and new-born genetic testing Marketby Diagnostic, 2018–2028(USD Billion)
10. Global Prenatal and new-born genetic testing Marketshare by End-Use ,2020 and 2028 (USD Billion)
11. Global Prenatal and new-born genetic testing Marketby Hospitals , 2018–2028(USD Billion)
12. Global Prenatal and new-born genetic testing Marketby Maternity & Specialty Clinics, 2018–2028(USD Billion)
13. Global Prenatal and new-born genetic testing Marketby Diagnostic Units, 2018–2028(USD Billion)
14. Global Prenatal and new-born genetic testing Marketshare, by Region, 2020 and 2028
15. North America Prenatal and new-born genetic testing Market, 2018–2028(USD Billion)
16. Europe Prenatal and new-born genetic testing Market, 2018–2028(USD Billion)
17. Asia Pacific Prenatal and new-born genetic testing Market, 2018–2028(USD Billion)
18. Latin America Prenatal and new-born genetic testing Market, 2018–2028(USD Billion)
19. The Middle East and Africa Prenatal and new-born genetic testing Market, 2018–2028(USD Billion)
List of Tables
1. Global Prenatal and new-born genetic testing Market: snapshot
2. Drivers of the Prenatal and new-born genetic testing Market: impact analysis
3. North America Prenatal and new-born genetic testing Market revenue, By Technology ,2018–2028(USD Billion)
4. North America Prenatal and new-born genetic testing Market revenue, By End-Use ,2018–2028(USD Billion)
5. The U.S. Prenatal and new-born genetic testing Market revenue, By Technology ,2018–2028(USD Billion)
6. The U.S. Prenatal and new-born genetic testing Market revenue, By End-Use ,2018–2028(USD Billion)
7. Rest of North America Prenatal and new-born genetic testing Market revenue, By Technology ,2018–2028(USD Billion)
8. Rest of North America Prenatal and new-born genetic testing Market revenue, By End-Use ,2018–2028(USD Billion)
9. Europe Prenatal and new-born genetic testing Market revenue, By Technology ,2018–2028(USD Billion)
10. Europe Prenatal and new-born genetic testing Market revenue, By End-Use ,2018–2028(USD Billion)
11. UK Prenatal and new-born genetic testing Market revenue, By Technology ,2018–2028(USD Billion)
12. UK Prenatal and new-born genetic testing Market revenue, By End-Use ,2018–2028(USD Billion)
13. France Prenatal and new-born genetic testing Market revenue, By Technology ,2018–2028(USD Billion)
14. France Prenatal and new-born genetic testing Market revenue, By End-Use ,2018–2028(USD Billion)
15. Germany Prenatal and new-born genetic testing Market revenue, By Technology ,2018–2028(USD Billion)
16. Germany Prenatal and new-born genetic testing Market revenue, By End-Use ,2018–2028(USD Billion)
17. Rest of Europe Prenatal and new-born genetic testing Market revenue, By Technology ,2018–2028(USD Billion)
18. Rest of Europe Prenatal and new-born genetic testing Market revenue, By End-Use ,2018–2028(USD Billion)
19. Asia Pacific Prenatal and new-born genetic testing Market revenue, By Technology ,2018–2028(USD Billion)
20. Asia Pacific Prenatal and new-born genetic testing Market revenue, By End-Use ,2018–2028(USD Billion)
21. China Prenatal and new-born genetic testing Market revenue, By Technology ,2018–2028(USD Billion)
22. China Prenatal and new-born genetic testing Market revenue, By End-Use ,2018–2028(USD Billion)
23. Japan Prenatal and new-born genetic testing Market revenue, By Technology ,2018–2028(USD Billion)
24. Japan Prenatal and new-born genetic testing Market revenue, By End-Use ,2018–2028(USD Billion)
25. India Prenatal and new-born genetic testing Market revenue, By Technology ,2018–2028(USD Billion)
26. India Prenatal and new-born genetic testing Market revenue, By End-Use ,2018–2028(USD Billion)
27. Rest of Asia Pacific Prenatal and new-born genetic testing Market revenue, By Technology ,2018–2028(USD Billion)
28. Rest of Asia Pacific Prenatal and new-born genetic testing Market revenue, By End-Use ,2018–2028(USD Billion)
29. Latin America Prenatal and new-born genetic testing Market revenue, By Technology ,2018–2028(USD Billion)
30. Latin America Prenatal and new-born genetic testing Market revenue, By End-Use ,2018–2028(USD Billion)
31. Brazil Prenatal and new-born genetic testing Market revenue, By Technology ,2018–2028(USD Billion)
32. Brazil Prenatal and new-born genetic testing Market revenue, By End-Use ,2018–2028(USD Billion)
33. Rest of Latin America Prenatal and new-born genetic testing Market revenue, By Technology ,2018–2028(USD Billion)
34. Rest of Latin America Prenatal and new-born genetic testing Market revenue, By End-Use ,2018–2028(USD Billion)
35. The Middle East and Africa Prenatal and new-born genetic testing Market revenue, By Technology ,2018–2028(USD Billion)
36. The Middle East and Africa Prenatal and new-born genetic testing Market revenue, By End-Use ,2018–2028(USD Billion)
37. Saudi Arabia Prenatal and new-born genetic testing Market revenue, By Technology ,2018–2028(USD Billion)
38. Saudi Arabia Prenatal and new-born genetic testing Market revenue, By End-Use ,2018–2028(USD Billion)
39. South Africa Prenatal and new-born genetic testing Market revenue, By Technology ,2018–2028(USD Billion)
40. South Africa Prenatal and new-born genetic testing Market revenue, By End-Use ,2018–2028(USD Billion)
41. Rest of the Middle East & Africa Prenatal and new-born genetic testing Market revenue, By Technology ,2018–2028(USD Billion)
42. Rest of the Middle East & Africa Prenatal and new-born genetic testing Market revenue, By End-Use ,2018–2028(USD Billion)
Technological breakthroughs in healthcare & growing awareness about advantages of prenatal & new-born genetic testing activities will steer prenatal and new-born genetic testing market growth. Surge in chromosomal disorders and occurrence of hereditary diseases will propel business growth. In addition to this, a prominent rise in acceptance of non-invasive prenatal testing activities will scale up expansion of prenatal and new-born genetic testing industry size during forecast timeline. Growing occurrence of genetic disorders in infants has translated into need for prenatal and new-born genetic testing activities, thereby driving prenatal and new-born genetic testing market trends.
According to Zion market research report, the global Prenatal and new-born genetic testing market accrued earnings worth approximately 4.7(USD Billion) in 2020 and is predicted to gain revenue of about 10.11(USD Billion) by 2028, is set to record a CAGR of nearly 11.8% over the period from 2021 to 2028.
North America will contribute lucratively towards the global market size over the estimated timeline. The regional market surge is due to supportive government healthcare policies along with easy availability of new bio-techniques including real-time PCR and multiplex PCR systems. Apart from this, rise in cases of genetic diseases in infants and demand for minimally invasive genetic screening in countries such as the U.S. will create lucrative growth avenues for prenatal and new-born genetic testing market in North America over forecast period. Surge in pregnancies in women after 35 years has posed a risk of child being born with anomalies and this has prompted need for prenatal and new-born genetic testing activities, thereby promulgating growth in size of prenatal and new-born genetic testing market in North American sub-continent.
The key market participants include Natera, Ariosa Diagnostics (Roche), Trivitron Healthcare, Sequenom, Berry Genomics, Qiagen, BGI, Biorad, Illumina, Laboratory Corporation of America, and Verinata Health.
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed